Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

ONE Gas Stock Seeks Momentum Shift Amid Market Pressure

Robert Sasse by Robert Sasse
September 11, 2025
in Analysis, Energy & Oil, Trading & Momentum, Turnaround
0
ONE Gas Stock
0
SHARES
173
VIEWS
Share on FacebookShare on Twitter

Natural gas utility ONE Gas is navigating a period of significant market volatility, with recent trading activity pointing toward continued downward momentum. Despite brief attempts at recovery, selling pressure has emerged as the dominant force shaping the stock’s trajectory.

Technical Indicators Flash Warning Signals

The stock is currently grappling with substantial selling pressure. Trading on Monday saw shares decline by 1.93 percent to $74.52, accompanied by notably elevated trading volume of 400,000 shares. A minor rebound of 0.13 percent to $75.22 in the previous session appears to represent merely a temporary pause within a broader downward trend. Since reaching its peak on August 22, ONE Gas shares have declined by 3.21 percent.

From a technical perspective, both short-term and long-term moving averages are generating clear sell signals. The breach of a critical pivot point in late August has further confirmed the bearish reversal in the stock’s price direction.

Strong Fundamentals Provide Counterbalance

Despite these technical challenges, the company maintains confident full-year projections:

  • 2025 Net Income: $254-261 million
  • Earnings Per Share: $4.20-$4.32
  • Capital Investment Program: $750 million

The upgraded annual guidance benefits from recent rate case approvals, including a $41.1 million increase in Oklahoma. Business expansion initiatives in growth markets like Texas and Oklahoma, supported by $180 million in investments, are expected to provide additional operational momentum.

Should investors sell immediately? Or is it worth buying ONE Gas?

The critical question remains whether these solid fundamental metrics can overcome the technical damage. Recent quarterly results offered a mixed preview: while revenue showed improvement, EPS of $0.53 fell short of analyst expectations.

Analyst Sentiment Remains Cautiously Positive

Wall Street opinions present a divided landscape. The average price target of $77.64 suggests potential upside of 3.65 percent, though the range of assessments varies considerably:

  • Highest Price Target: $89.00 (Wells Fargo)
  • Lowest Price Target: $71.00 (Morgan Stanley)
  • Recommendations: 4 Buy, 3 Hold

A modest reduction in short positions indicates some growing confidence in the company’s longer-term outlook.

Energy Market Volatility Adds Uncertainty

Fluctuating natural gas prices continue to represent a significant factor influencing performance. The commodity currently trades at $3.02 with a slight daily decline of 0.36 percent. While monthly performance shows a gain of 7.48 percent, such price volatility directly impacts the utility’s operational margin development.

Market observers are watching closely to determine whether ONE Gas’s fundamental strengths will prove sufficient to reverse the current technical downtrend. The coming trading sessions will reveal whether buyers return to the market or if sellers maintain their control over price action.

Ad

ONE Gas Stock: Buy or Sell?! New ONE Gas Analysis from March 25 delivers the answer:

The latest ONE Gas figures speak for themselves: Urgent action needed for ONE Gas investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

ONE Gas: Buy or sell? Read more here...

Tags: ONE Gas
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Next Post
ASML Stock

ASML's Billion-Euro AI Investment Signals New Era for Chip Manufacturing

Plug Power Stock

Plug Power's Strategic Gambit: A Bid to Reverse Fortunes

Coca-Cola Stock

Coca-Cola Shares Face Mounting Pressure from Market and Technical Challenges

Recommended

Banner Stock

All Eyes on Fed as Banner Corporation Awaits Rate Decision

6 months ago
Dynatrace Holdings LLC Stock

Dynatrace Holdings LLC Stock: Strong Q1 Performance Beats Expectations

8 months ago
MP Materials Stock

MP Materials: Record Production Amid Financial Headwinds

4 months ago
Omv Stock

OMV Faces Critical Juncture as Qatar Threatens European Gas Supplies

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Trending

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

by Jackson Burston
March 25, 2026
0

Fair Isaac Corporation, the company behind the ubiquitous FICO credit score, is facing a dual-pronged assault that...

Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem
  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com